百济神州:2024 年产品收入高速增长 扭亏在望

和讯网
03 Mar

【国泰君安:百济神州运营持续提效,2025 年预计扭亏】百济神州泽布替尼高速放量,美国新患份额跃居第一,研发管线步入加速收获期。公司 2024 年产品收入 37.8 亿美元,同比+72.6%;2024Q4 产品收入 11.2 亿美元,同比+77.3%。随着运营效率提高,产品收入增长超经营费用增长,非 GAAP 准则下 2024 年经营利润 4500 万美元,扭亏为盈;GAAP 准则下经营亏损持续...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10